trial
as of 2026-07-01A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia
NCTId NCT02192723
at a glance
— · Completed
Enrollment 550 (actual)
Sponsored by Beijing HuiLongGuan Hospital
Primary completion 2014-06
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
550 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2012-06
Primary completion
2014-06
Eligibility
ALL · 25 Years · 60 Years
Interventions & indications
Sponsors
Beijing HuiLongGuan HospitalLead Sponsor
Investigators
1
Zhi-Ren Wang, MD, PhDStudy Director
Sites
1 total
Beijing, China
Facts & assertions
4 sourced
Enrollment
550
Phase
NA
Primary Completion Date
2014-06
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
company
indication
indication
indication
investigator
person